Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    9352883 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intestinal Microbial Dysbiosis in Chinese Infants With Short Bowel Syndrome With Different Complications
Conditions: Short Bowel Syndrome;   Complications
Intervention: Other: Complications
2 Completed
Has Results
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
Condition: Short Bowel Syndrome
Interventions: Drug: Placebo;   Drug: Teduglutide 0.05 mg/kg/d;   Drug: Teduglutide 0.1 mg/kg/d

Indicates status has not been verified in more than two years